Company · CIK 0001402328 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Sunshine Biopharma Inc. · SBFM
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 7, 2026 AForm 4 → | Aug 11, 4:23 pm EDT | David NatanDirector | 58,300 | — | — | 68,300 | — | |
| Aug 27, 2018 AForm 4 → | Sep 14, 10:23 am EDT | Abderrazzak MerzoukiChief Operating Officer, Director | 38,000,000 | $0.001 | $38,000 | 118,467,000 | — | plan? late |
| Aug 27, 2018 AForm 4 → | Sep 14, 10:14 am EDT | Camille SebaalySecretary, Director | 38,000,000 | $0.001 | $38,000 | 117,234,373 | — | plan? late |
| Aug 27, 2018 AForm 4 → | Sep 14, 10:08 am EDT | Steve N. SlilatyChief Executive Officer, Director | 38,000,000 | $0.001 | $38,000 | 117,384,373 | — | plan? late |
| Jun 20, 2018 AForm 4 → | Jun 28, 5:57 pm EDT | Abderrazzak MerzoukiChief Operating Officer, Director | 27,000,000 | $0.001 | $27,000 | 80,467,000 | — | plan? late |
| Jun 20, 2018 AForm 4 → | Jun 28, 5:52 pm EDT | Camille SebaalySecretary, Director | 27,000,000 | $0.001 | $27,000 | 79,234,373 | — | plan? late |
| Jun 20, 2018 AForm 4 → | Jun 28, 5:47 pm EDT | Steve N. SlilatyChief Executive Officer, Director | 27,000,000 | $0.001 | $27,000 | 79,384,373 | — | plan? late |
| Jul 20, 2017 AForm 4 → | Sep 8, 9:55 am EDT | Abderrazzak MerzoukiChief Operating Officer, Director | 14,000,000 | $0.001 | $14,000 | 53,467,000 | — | plan? late |
| Jul 20, 2017 AForm 4 → | Sep 8, 9:45 am EDT | Camille SebaalySecretary, Director | 14,000,000 | $0.001 | $14,000 | 52,234,373 | — | plan? late |
| Jul 20, 2017 AForm 4 → | Sep 8, 9:28 am EDT | Steve N. SlilatyChief Executive Officer, Director | 14,000,000 | $0.001 | $14,000 | 52,384,373 | — | plan? late |
| Dec 6, 2016 AForm 4 → | Dec 15, 7:58 pm EST | Abderrazzak MerzoukiChief Operating Officer, Director | 26,000,000 | $0.001 | $26,000 | 39,467,000 | — | plan? late |
| Dec 6, 2016 AForm 4 → | Dec 15, 7:50 pm EST | Camille SebaalyCFO and Secretary, Director | 26,000,000 | $0.001 | $26,000 | 38,234,373 | — | plan? late |
| Dec 6, 2016 AForm 4 → | Dec 15, 7:45 pm EST | Steve N. SlilatyChief Executive Officer, Director | 26,000,000 | $0.001 | $26,000 | 38,384,373 | — | plan? late |
| Oct 10, 2016 JForm 4 → | Nov 7, 12:10 pm EST | Advanomics Corp10% Owner | 136,861,968 | — | — | 215,014,224 | — | plan? late |
| Oct 10, 2016 JForm 4 → | Nov 7, 12:01 pm EST | Camille SebaalyCFO and Secretary, Director, 10% Owner | 129,468,927 | — | — | 129,468,927 | — | plan? late |
| Oct 10, 2016 JForm 4 → | Nov 7, 11:41 am EST | Steve N. SlilatyChief Executive Officer, Director, 10% Owner | 136,861,968 | — | — | 215,014,224 | — | plan? late |
| Jul 8, 2016 JForm 4 → | Aug 1, 11:35 am EDT | Steve N. SlilatyChief Executive Officer, Director, 10% Owner | 321,305,416 | $0.0026 | $835,394 | 351,876,192 | — | plan? late |
| Apr 22, 2016 AForm 4 → | Apr 26, 8:49 am EDT | Steve N. SlilatyChief Executive Officer, Director | 12,000,000 | $0.007 | $84,000 | 12,384,373 | — | plan? |
| Apr 22, 2016 AForm 4 → | Apr 25, 7:35 am EDT | Camille SebaalyCFO and Secretary, Director | 12,000,000 | $0.007 | $84,000 | 12,234,373 | — | plan? |
| Apr 22, 2016 AForm 4 → | Apr 25, 7:30 am EDT | Abderrazzak MerzoukiChief Operating Officer, Director | 12,000,000 | $0.007 | $84,000 | 13,467,000 | — | plan? |
| Apr 12, 2016 PForm 4 → | Apr 26, 8:49 am EDT | Steve N. SlilatyChief Executive Officer, Director | 253,082 | $0.1976 | $50,009 | 30,570,776 | +0.83% | plan? late |
| May 27, 2015 PForm 4 → | Jun 1, 8:26 pm EDT | Steve N. SlilatyChief Executive Officer, Director, 10% Owner | 500,000 | $0.10 | $50,000 | 500,000 | — | plan? late |
| Jan 9, 2015 JForm 4 → | Jan 22, 11:48 am EST | Steve N. SlilatyChief Executive Officer, Director, 10% Owner | 1,350,000 | $0.02 | $27,000 | 384,373 | — | plan? late |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.